Welcome to the CropLife International database of published papers and reviews demonstrating the benefits and safety implications associated with the use of agricultural biotechnology products.
In 2016, global hectarage of biotech crops increased from 179.7 million hectares to 185.1 million hectares, a 3% increase equivalent to 5.4 million hectares. Since 1996, 2 billon hectares of arable land, a massive area more than twice the landmass of China or the United States, have been planted with biotech crops. In 2016, 26 countries in total, including 19 developing and 7 industrial countries, grew biotech crops. Developing countries grew 54% of biotech crops, compared to 46% for industrial nations. The leading countries growing biotech crops continued to be represented by the United States, Brazil, Argentina, Canada and India. Combined, these five countries planted 91% of the global biotech crop area. Four countries in Europe – Spain, Portugal, Czech Republic, and Slovakia grew more than 136,000 hectares of biotech maize in 2016, an increase of 17% from 2015, reflecting EU’s need for insect resistant maize.
While studies recording, demonstrating and quantifying the benefits of biotechnology are available, they can be difficult to find. The purpose of this database is to enable you to quickly and easily locate and access credible scientific information about the demonstrated benefits of agricultural biotechnology products and the safety implications associated with their use.
All the papers have either been published in peer-reviewed journals or have been prepared by organisations that have summarised peer-reviewed studies.
Papers are organised primarily by the different categories of impact of biotechnology, with links on the left column to each impact category. Clicking on the link provides a summary and description of the impact and a list of papers in the database that relate to the relevant impact category.
The database search allows you to further specify your filters to find the right paper of interest. This option is interactive with the search results updating as soon as a parameter is changed.
The list of studies is being continuously added to and updated, and your suggestions for the inclusion of additional studies are welcome via this form.
United States Government Policy for Institutional Overnight of Life Sciences Dual Use Research of Concern
United States Government Policy for Overnight of Life Sciences Dual Use Research of Concern
NIH Guidelines For Research Involving Recombinant Or Synthetic Nucleic Acid Molecules
Policy brief: Guidelines for the appropriate risk governance of synthetic biology
Emerging policy issues in synthetic biology